John J. Alam, EVP, Medicines Development & CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,980 shares at $38.54 ($76K) on 2006-12-13, disclosed to the SEC on 2006-12-15.
Scheduled sale ($76k) by EVP, Medicines Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.54 | 1,500 | $58K | 75.6% |
| 2 | $38.85 | 480 | $19K | 24.4% |
| Total | $38.62 avg | 1,980 | $76K | 100% |
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |